# 83831-142-50 · Carboplatin Injection · Avyxa Pharma, LLC — FDA drug shortage duration tracker

For 83831-142-50 · Carboplatin Injection · Avyxa Pharma, LLC, package ndc is 83831-142-50; generic name is Carboplatin Injection; manufacturer is Avyxa Pharma, LLC; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 83831-142-50 _(verified: appears in the quote below)_
- **Generic name:** Carboplatin Injection _(verified: appears in the quote below)_
- **Manufacturer:** Avyxa Pharma, LLC _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 04/28/2023 _(verified: appears in the quote below)_
- **Last update date:** 08/04/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1222 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Oncology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "04/28/2023", "package_ndc": "83831-142-50", "generic_name": "Carboplatin Injection", "contact_info": "877-595-7337; customerservice@avyxa.com", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/04/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)", "company_name": "Avyxa Pharma, LLC", "status": "Current"

### Status

> "update_date": "08/04/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)", "company_name": "Avyxa Pharma, LLC", "status": "Current"

### Last update date

> "update_date": "08/04/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)", "company_name": "Avyxa Pharma, LLC", "status": "Current"

### Dosage form

> "update_date": "08/04/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)", "company_name": "Avyxa Pharma, LLC", "status": "Current"

### Therapeutic category

> "update_date": "08/04/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)", "company_name": "Avyxa Pharma, LLC", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avyxa%20Pharma,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).